Healthcare -
Biotechnology - NASDAQ - US
$ 1.745
5.12 %
$ 124 M
Market Cap
-0.7
P/E
ZNTL - COST OF REVENUE
Cost of Revenue ZNTL - Zentalis Pharmaceuticals, Inc.
1.39 M
LAST VALUE
59.79%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR